Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc
Journal website http://www.jocmr.org

Case Report

Volume 4, Number 3, June 2012, pages 216-220


Remarkable Effect of Gefitinib Retreatment in a Lung Cancer Patient With Lepidic Predominat Adenocarcinoma who had Experienced Favorable Results From Initial Treatment With Gefitinib: A Case Report

Figure

Figure 1.
Figure 1. A: Initial chest CT scan, a consolidative mass in RML and RLL with multiple hematogenous metastatic nodules in BUL. B: Chest CT scan before treatment with 250 mg gefitinib, more increased consolidative mass in the right lung field. C: Chest CT scan 6 months after treatment with 250 mg gefitinib, much improved consolidative mass in the right lung and markedly improved hematogenous metastasis in BUL. D: Chest CT scan 13 month after treatment with 250 mg gefitinib, no interval change compared with the previous CT scan.